New activity is brewing for LENSAR ( (LNSR) ). The company has submitted a Form DEFM14A to the SEC, indicating an upcoming shareholder vote. This form gives shareholders all the information they need to develop an informed vote. Read on to learn more about the proposed company action.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
LENSAR, Inc. announced a proposed merger with Alcon Research, LLC, where LENSAR will become a wholly owned subsidiary of Alcon. The merger agreement, dated March 23, 2025, offers LENSAR stockholders $14.00 per share in cash and a contingent value right of $2.75 per share, representing a significant premium over recent trading prices. The special meeting for stockholders to vote on the merger is scheduled for July 2, 2025. The merger is expected to strengthen LENSAR’s market position and provide substantial returns to its stakeholders.
The most recent analyst rating on (LNSR) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on LENSAR stock, see the LNSR Stock Forecast page.
Spark’s Take on LNSR Stock
According to Spark, TipRanks’ AI Analyst, LNSR is a Neutral.
LENSAR’s overall score is primarily influenced by its financial challenges, including ongoing losses and negative equity. However, strong revenue growth and a promising merger with Alcon provide potential for future improvement. Technical indicators suggest stable momentum, while valuation remains limited by negative earnings. The earnings call and merger news contribute positively but are offset by the financial issues.
To see Spark’s full report on LNSR stock, click here.
More about LENSAR
LENSAR, Inc. operates in the medical technology industry, focusing on developing advanced laser systems for cataract surgery. The company aims to enhance precision and outcomes in ophthalmic procedures, catering to healthcare providers and patients seeking innovative surgical solutions.
Average Trading Volume: 179,022
Technical Sentiment Signal: Buy
Current Market Cap: $166.4M
See more insights into LNSR stock on TipRanks’ Stock Analysis page.